US Broker Ratings

Oculis Holding AG (OCS) Stock Analysis: A Biotech Player with a 65% Upside Potential

Oculis Holding AG (NASDAQ: OCS) is capturing investor attention with its significant growth potential in the biopharmaceutical landscape. With a remarkable potential upside of 65.30%, this..

Mind Medicine (MNMD) Investor Outlook: Exploring a Potential 90% Upside in the Biotech Arena

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), a promising player in the biotechnology sector, is capturing investor attention with its ambitious clinical-stage biopharmaceutical endeavors. Headquartered in New..

Akebia Therapeutics, Inc. (AKBA): Investor Outlook on a Biopharma with 262% Upside Potential

Investors seeking high-growth opportunities in the healthcare sector may find Akebia Therapeutics, Inc. (NASDAQ: AKBA) an intriguing prospect. With a focus on developing therapeutics for kidney..

Nurix Therapeutics, Inc. (NRIX) Stock Analysis: Unveiling an 88% Upside Potential in Biotech

For investors seeking promising opportunities in the biotechnology sector, Nurix Therapeutics, Inc. (NASDAQ: NRIX) presents a compelling case with significant upside potential. Currently trading at $15.95,..

Gyre Therapeutics, Inc. (GYRE) Stock Analysis: Exploring a Promising 139.68% Upside Potential

Gyre Therapeutics, Inc. (NASDAQ: GYRE) stands out in the biotechnology sector, promising a substantial potential upside of 139.68% based on current analyst ratings. As investors navigate..

KalVista Pharmaceuticals, Inc. (KALV) Stock Analysis: Unveiling a 134.57% Potential Upside in Biotech Innovation

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) is carving a niche in the biotechnology sector with its innovative approach to drug development, focusing on therapies for diseases with..

Rocket Pharmaceuticals, Inc. (RCKT) Stock Analysis: Exploring a 155% Potential Upside in the Biotech Sector

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) stands out in the biotechnology sector, attracting significant attention from investors with its compelling potential upside of 155% based on current..

Spyre Therapeutics, Inc. (SYRE) Stock Analysis: Biotechnology Innovator with a 71% Upside Potential

Spyre Therapeutics, Inc. (NASDAQ: SYRE), a burgeoning player in the biotechnology sector, is capturing investor attention with its promising therapeutic developments aimed at combating inflammatory bowel..

Avanos Medical, Inc. (AVNS) Stock Analysis: A Healthcare Play with a Focus on Innovative Pain Solutions

Avanos Medical, Inc. (NYSE: AVNS), a prominent player in the healthcare sector, specifically in the medical devices industry, is attracting attention with its innovative approach to..

Nutex Health Inc. (NUTX) Stock Analysis: A 145% Upside Potential with Strong Analyst Support

For investors scanning the healthcare sector for promising opportunities, Nutex Health Inc. (NUTX) stands out with a compelling blend of robust revenue growth and substantial upside..

Bicycle Therapeutics plc (BCYC) Stock Analysis: Exploring a 297% Potential Upside Opportunity

Bicycle Therapeutics plc (NASDAQ: BCYC) presents an intriguing opportunity in the biotechnology sector, particularly for investors with a penchant for high-risk, high-reward plays. With a focus..

Avadel Pharmaceuticals plc (AVDL) Stock Analysis: Navigating the Path to Growth in the Biopharmaceutical Sector

Avadel Pharmaceuticals plc (NASDAQ: AVDL) stands at an intriguing junction for investors interested in the healthcare sector, particularly within the specialty and generic drug manufacturing industry...

Savara, Inc. (SVRA) Stock Analysis: Exploring a Promising 109.54% Upside in Biotech

Savara, Inc. (NASDAQ: SVRA) is making waves in the biotechnology sector, particularly for investors with an appetite for high-risk, high-reward opportunities. As a clinical-stage biopharmaceutical company,..

SI-BONE, Inc. (SIBN) Stock Analysis: Exploring a 61.58% Potential Upside Amidst Strong Buy Ratings

SI-BONE, Inc. (NASDAQ: SIBN) stands out in the healthcare sector with its focus on the medical devices industry. The company has carved a niche by addressing..

Nuvation Bio Inc. (NUVB) Stock Analysis: Exploring 111.55% Potential Upside in the Biotech Sector

Nuvation Bio Inc. (NASDAQ: NUVB) stands out in the biotechnology sector with a staggering potential upside of 111.55%, capturing the attention of investors looking for high-growth..

Arcus Biosciences (RCUS): Exploring a 64.75% Potential Upside in Cancer Therapy Innovations

Arcus Biosciences, Inc. (NASDAQ: RCUS), based in Hayward, California, is capturing the attention of investors with its innovative approach in the biotechnology sector, specifically targeting cancer..

Bicara Therapeutics Inc. (BCAX)

⚠️ No article content returned.

..

Evolus, Inc. (EOLS) Stock Analysis: Exploring a 243.92% Potential Upside in the Healthcare Sector

Evolus, Inc. (NASDAQ: EOLS), a key player in the healthcare sector specializing in specialty and generic drug manufacturing, has garnered significant attention from investors due to..

Fulgent Genetics, Inc. (FLGT) Investor Outlook: Capitalizing on a 41.99% Potential Upside

Fulgent Genetics, Inc. (FLGT) is making waves in the healthcare sector, specifically within the Diagnostics & Research industry. With a market capitalization of approximately $732.93 million,..

Trevi Therapeutics, Inc. (TRVI) Stock Analysis: A 96.94% Potential Upside That Investors Can’t Ignore

Trevi Therapeutics, Inc. (NASDAQ: TRVI), a clinical-stage biopharmaceutical company, is garnering significant attention from investors with an impressive potential upside of nearly 97%. Specializing in the..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds